Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A fixed-dose **combination of ibuprofen and sodium bicarbonate**. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that acts as a non-selective inhibitor of cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2), thereby reducing prostaglandin synthesis, leading to analgesic, anti-inflammatory, and antipyretic effects[6]. **Sodium bicarbonate** is an antacid that rapidly neutralizes stomach acid and raises gastric pH, which can enhance the dissolution and absorption of ibuprofen, providing faster onset of action[5]. Combination aims to provide rapid pain relief and address gastrointestinal discomfort or delay in absorption related to ibuprofen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + sodium bicarbonate.